AEGR
Aegerion Pharmaceuticals
AEGR
AEGR
Delisted
AEGR was delisted on the 29th of November, 2016.
129 hedge funds and large institutions have $1.09B invested in Aegerion Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 51 increasing their positions, 41 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
29% less capital invested
Capital invested by funds: $1.54B → $1.09B (-$446M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
129
Holding in Top 10
1
Calls
$29.8M
Puts
$23.9M
Top Buyers
| 1 | +$93M | |
| 2 | +$49.6M | |
| 3 | +$47.9M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$17.2M |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$16.3M |
Top Sellers
| 1 | -$108M | |
| 2 | -$49M | |
| 3 | -$43.1M | |
| 4 |
CCM
Consonance Capital Management
New York
|
-$35M |
| 5 |
PC
PointState Capital
New York
|
-$21.7M |